The Association of Statin Therapy with Incident Diabetes: Evidence, Mechanisms, and Recommendations

A. Agarwala, S. Kulkarni, T. Maddox

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations


Purpose of Review: Recent studies have demonstrated a higher risk of incident diabetes associated with statin use, causing concern among patients and clinicians. In this review, we will assess the evidence and proposed mechanisms behind statin therapy and its association with incident diabetes. We will then review the current recommendations for statin use in light of this association and suggest next steps for clinicians managing these patients and researchers exploring this phenomenon. Recent Findings: The annual risk of developing new-onset diabetes with statin treatment is approximately 0.1%. In comparison, the absolute risk reduction of major coronary events with statin use is approximately 0.42% annually. Summary: Statins are associated with the development of incident diabetes, particularly among those with predisposing risk factors for diabetes. However, the benefit of statin use among these patients in preventing major coronary events strongly favors statin use despite its risk of incident diabetes.

Original languageEnglish
Article number50
JournalCurrent Cardiology Reports
Issue number7
StatePublished - Jul 1 2018


  • Atherosclerotic cardiovascular disease (ASCVD)
  • Diabetes
  • Low-density lipoprotein cholesterol (LDL-C)
  • Statin


Dive into the research topics of 'The Association of Statin Therapy with Incident Diabetes: Evidence, Mechanisms, and Recommendations'. Together they form a unique fingerprint.

Cite this